Expression of 25 hydroxyvitamin D3-1α-hydroxylase in human endometrial tissue

被引:26
作者
Becker, Steffi [1 ]
Cordes, Tim [1 ]
Diesing, Dagmar [1 ]
Diedrich, Klaus [1 ]
Friedrich, Michael [1 ]
机构
[1] Univ Schleswig Holstein, Dept Obstet & Gynaecol, D-23562 Lubeck, Germany
关键词
extrarenal 1,25-dihydroxyvitamin D-3; 1; alpha-OHase; alternative splicing; endometrial cancer;
D O I
10.1016/j.jsbmb.2006.12.075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1,25(OH)(2)D-3 (calcitriol) has been shown to play an important role in cell proliferation, differentiation and immune responsiveness. The enzyme responsible for calcitriol synthesis 25 hydroxyvitamin D-3-1 alpha-hydroxylase (1 alpha-OHase) has been reported in many human tissues. The aim of this study was to investigate the expression of 1 alpha-OHase in gynaecological tissues. Using a highly specific nested touchdown PCR we examined the expression of 1 alpha-OHase in normal and malignant endometrial tissue and in human endometrial Ishikawa cells. In addition, we analyzed the protein expression of 1 alpha-OHase by Western blot. The expression of 1 alpha-OHase in normal and malignant endometrial tissue and Ishikawa cells was detected and splice variants of the enzyme in Ishikawa cells were identified. These data suggest an alternative splicing of 1 alpha-OHase in malignant endometrial tissue and cells. We postulate that the expression of 1 alpha-OHase gene variants may contribute to the anti proliferative effects of calcitriol. In conclusion, the modulation of the 1 alpha-OHase opens up a new target for vitamin D-3 related therapies in endometrial cancer. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:771 / 775
页数:5
相关论文
共 26 条
[1]   NONGENOMIC ACTIONS OF THE STEROID-HORMONE 1-ALPHA,25-DIHYDROXYVITAMIN D-3 [J].
BARAN, DT .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 56 (03) :303-306
[2]   Constitutive expression of 25-hydroxyvitamin D3-1α-hydroxylase in a transformed human proximal tubule cell line:: Evidence for direct regulation of vitamin D metabolism by calcium [J].
Bland, R ;
Walker, EA ;
Hughes, SV ;
Stewart, PM ;
Hewison, N .
ENDOCRINOLOGY, 1999, 140 (05) :2027-2034
[3]  
Cantorna MT, 2005, J RHEUMATOL, V32, P11
[4]   Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D-3 [J].
Christakos, S ;
RavalPandya, M ;
Wernyj, RP ;
Yang, W .
BIOCHEMICAL JOURNAL, 1996, 316 :361-371
[5]   Vitamin D3 metabolism in human glioblastoma multiforme:: Functionality of CYP27B1 splice variants, metabolism of calcidiol and effect of calcitriol [J].
Diesel, B ;
Radermacher, J ;
Bureik, M ;
Bernhardt, R ;
Seifert, M ;
Reichrath, J ;
Fischer, U ;
Meese, E .
CLINICAL CANCER RESEARCH, 2005, 11 (15) :5370-5380
[6]   Towards a complete picture of splice variants of the gene for 25-hydroxyvitamin D31α-hydroxylase in brain and skin cancer [J].
Diesel, B ;
Seifert, M ;
Radermacher, J ;
Fischer, U ;
Tilgen, W ;
Reichrath, J ;
Meese, E .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :527-532
[7]  
Flanagan JN, 2003, RECENT RESULTS CANC, V164, P157
[8]   1-ALPHA,25-DIHYDROXYVITAMIN D-3 INHIBITS THE INVASIVE POTENTIAL OF HUMAN BREAST-CANCER CELLS IN-VITRO [J].
HANSEN, CM ;
FRANDSEN, TL ;
BRUNNER, N ;
BINDERUP, L .
CLINICAL & EXPERIMENTAL METASTASIS, 1994, 12 (03) :195-202
[9]   Vitamin D and cancer:: Effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis [J].
Hansen, CM ;
Binderup, L ;
Hamberg, KJ ;
Carlberg, C .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2001, 6 :D820-D848
[10]  
HSY JY, 2001, CANCER RES, V61, P2852